MYCOPHENOLATE MOFETIL; A REVIEW OF INDICATIONS AND USE IN A LARGE TERTIARY HOSPITAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Geevasinga n.; WALLMAN L.; Katelaris c.h.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Allergy, Asthma and Immunology Year:2005 | Volume:4 | Issue:4 Page(s): 159-166

Download Full-Text

View:

418

Download:

316

Cites:

Information Journal Paper

Title

MYCOPHENOLATE MOFETIL; A REVIEW OF INDICATIONS AND USE IN A LARGE TERTIARY HOSPITAL

Author(s)

Geevasinga n. | WALLMAN L. | Katelaris c.h. | Issue Writer Certificate

Keywords

IMMUNOLOGICAL DISEASES

IMMUNOLOGY

IMMUNOSUPPRESSANTS

MYCOPHENOLIC ACID

MYCOPHENOLATE MOFETIL

Abstract

Mycophenolate Mofetil (MMF) has been registered for use in Australia since 1997 for prophylaxis of solid organ allograft rejection. MMF is now increasingly used for indications outside solid organ allograft rejection, often with limited supporting efficacy data. The purpose of this audit was to examine the patterns of use, reported side effects and cost impact of the drug in the Clinical and IMMUNOLOGY and Allergy (CIA) unit of Australia’s largest teaching hospital.Prescription patterns for MMF by consultant immunologists at Westmead hospital between 2000 and 2004 were obtained from the pharmacy. These data were sorted for non-S100 indications. A single immunologist then reviewed the patient files. We also reviewed the literature on the use of this promising immunosuppressant. There has been a marked increase in use of MMF since year 2000 by the Department of CIA. A total of 75 patients were prescribed MMF for non-S100 indications. Common indications were systemic lupus erythematosus, pemphigus vulgaris, chronic idiopathic urticaria, myasthenia gravis, polymyositis, atopic dermatitis, Sjögren’s disease, uveitis and vasculitis. It is clear that MMF has potential for use in a number of immunological disorders because of its relatively benign side effect profile and observed efficacy. Double blinded, placebo-controlled, multicentre trials are necessary to establish its therapeutic role. Our study highlights some of the conditions for which this agent is useful.

Cites

No record.

References

No record.

Cite

APA: Copy

Geevasinga, n., WALLMAN, L., & Katelaris, c.h.. (2005). MYCOPHENOLATE MOFETIL; A REVIEW OF INDICATIONS AND USE IN A LARGE TERTIARY HOSPITAL. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), 4(4), 159-166. SID. https://sid.ir/paper/291108/en

Vancouver: Copy

Geevasinga n., WALLMAN L., Katelaris c.h.. MYCOPHENOLATE MOFETIL; A REVIEW OF INDICATIONS AND USE IN A LARGE TERTIARY HOSPITAL. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI)[Internet]. 2005;4(4):159-166. Available from: https://sid.ir/paper/291108/en

IEEE: Copy

n. Geevasinga, L. WALLMAN, and c.h. Katelaris, “MYCOPHENOLATE MOFETIL; A REVIEW OF INDICATIONS AND USE IN A LARGE TERTIARY HOSPITAL,” IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), vol. 4, no. 4, pp. 159–166, 2005, [Online]. Available: https://sid.ir/paper/291108/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops